Scholarly Index
Carola Berking
Universitätsklinikum Erlangen; 25,057 total citations; 514 total publications; best world rank #32
Universitätsklinikum Erlangen
25,057Total citations
514Total publications
76H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Nonmelanoma Skin Cancer Studies | Lifetime | 45 | DE 6 | 99.27 |
| Cutaneous Melanoma Detection and Management | Lifetime | 63 | DE 5 | 99.30 |
| Melanoma and MAPK Pathways | Lifetime | 137 | DE 13 | 98.40 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 766 | DE 43 | 98.39 |
| CAR-T cell therapy research | Lifetime | 796 | DE 68 | 97.91 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 250 | DE 21 | 97.45 |
| Skin Protection and Aging | Lifetime | 271 | DE 36 | 97.48 |
| melanin and skin pigmentation | Lifetime | 348 | DE 22 | 96.41 |
| Cancer and Skin Lesions | Lifetime | 753 | DE 54 | 94.95 |
| Ocular Oncology and Treatments | Lifetime | 634 | DE 51 | 92.23 |
| Cutaneous Melanoma Detection and Management | 2021-2025 | 37 | DE 7 | 98.69 |
| Nonmelanoma Skin Cancer Studies | 2021-2025 | 32 | DE 6 | 97.71 |
| Melanoma and MAPK Pathways | 2021-2025 | 55 | DE 10 | 96.90 |
| Immunotherapy and Immune Responses | 2021-2025 | 415 | DE 27 | 94.93 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 91 | DE 9 | 95.27 |
| Ocular Oncology and Treatments | 2021-2025 | 99 | DE 6 | 92.27 |